|
GB9708611D0
(en)
*
|
1997-04-28 |
1997-06-18 |
Univ Cardiff |
Chemical compounds
|
|
GB9716231D0
(en)
|
1997-07-31 |
1997-10-08 |
Amersham Int Ltd |
Base analogues
|
|
WO1999008110A1
(en)
|
1997-08-08 |
1999-02-18 |
Newbiotics, Inc. |
Methods and compositions for overcoming resistance to biologic and chemotherapy
|
|
US7462605B2
(en)
|
1998-01-23 |
2008-12-09 |
Celmed Oncology (Usa), Inc. |
Phosphoramidate compounds and methods of use
|
|
IL137164A0
(en)
|
1998-01-23 |
2001-07-24 |
Newbiotics Inc |
Enzyme catalyzed therapeutic agents
|
|
US6683061B1
(en)
|
1999-07-22 |
2004-01-27 |
Newbiotics, Inc. |
Enzyme catalyzed therapeutic activation
|
|
BR0012676A
(pt)
|
1999-07-22 |
2003-07-01 |
Newbiotics Inc |
Métodos para tratamento de tumores resistentes a terapia
|
|
GB0009486D0
(en)
*
|
2000-04-17 |
2000-06-07 |
Univ Cardiff |
Chemical compounds
|
|
GB0011203D0
(en)
*
|
2000-05-09 |
2000-06-28 |
Univ Cardiff |
Chemical compounds
|
|
AU2003225701A1
(en)
|
2002-03-08 |
2003-09-22 |
Glen Research Corporation |
Fluorescent nitrogenous base and nucleosides incorporating same
|
|
LT1576138T
(lt)
|
2002-11-15 |
2017-06-26 |
Idenix Pharmaceuticals Llc |
2`-šakoti nukleozidai derinyje su interferonu ir flaviviridae mutacija
|
|
GB0609178D0
(en)
|
2006-05-09 |
2006-06-21 |
Univ Cardiff |
Novel compounds
|
|
US20080261913A1
(en)
|
2006-12-28 |
2008-10-23 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of liver disorders
|
|
US9216979B2
(en)
|
2009-10-16 |
2015-12-22 |
Melinta Therapeutics, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
WO2011047320A2
(en)
|
2009-10-16 |
2011-04-21 |
Rib-X Pharmaceuticals, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
KR101972992B1
(ko)
*
|
2009-10-16 |
2019-04-29 |
멜린타 서브시디어리 코프. |
항미생물성 화합물 및 이의 제조 방법 및 사용 방법
|
|
GB201016855D0
(en)
*
|
2010-10-06 |
2010-11-17 |
Nucana Biomed Ltd |
Chemical compounds
|
|
US9243025B2
(en)
|
2011-03-31 |
2016-01-26 |
Idenix Pharmaceuticals, Llc |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
|
KR20140065378A
(ko)
|
2011-04-15 |
2014-05-29 |
멜린타 테라퓨틱스, 인크. |
항미생물 화합물 및 그의 제조 방법과 사용 방법
|
|
GB201111779D0
(en)
|
2011-07-08 |
2011-08-24 |
Univ Cardiff |
Chemical compounds
|
|
AR088441A1
(es)
|
2011-09-12 |
2014-06-11 |
Idenix Pharmaceuticals Inc |
Compuestos de carboniloximetilfosforamidato sustituido y composiciones farmaceuticas para el tratamiento de infecciones virales
|
|
US8507460B2
(en)
|
2011-10-14 |
2013-08-13 |
Idenix Pharmaceuticals, Inc. |
Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
|
|
US9296778B2
(en)
|
2012-05-22 |
2016-03-29 |
Idenix Pharmaceuticals, Inc. |
3′,5′-cyclic phosphate prodrugs for HCV infection
|
|
JP6165848B2
(ja)
|
2012-05-22 |
2017-07-19 |
イデニク ファーマシューティカルズ エルエルシー |
肝疾患のためのｄ−アミノ酸化合物
|
|
WO2013177188A1
(en)
|
2012-05-22 |
2013-11-28 |
Idenix Pharmaceuticals, Inc. |
3',5'-cyclic phosphoramidate prodrugs for hcv infection
|
|
MX2014014323A
(es)
|
2012-05-25 |
2015-02-12 |
Janssen R & D Ireland |
Nucleosidos de espirooxetano de uracilo.
|
|
WO2014052638A1
(en)
|
2012-09-27 |
2014-04-03 |
Idenix Pharmaceuticals, Inc. |
Esters and malonates of sate prodrugs
|
|
EP2906579B1
(en)
|
2012-10-08 |
2018-04-18 |
Idenix Pharmaceuticals LLC. |
2'-chloro nucleoside analogs for hcv infection
|
|
US10723754B2
(en)
|
2012-10-22 |
2020-07-28 |
Idenix Pharmaceuticals Llc |
2′,4′-bridged nucleosides for HCV infection
|
|
EP2935304A1
(en)
|
2012-12-19 |
2015-10-28 |
IDENIX Pharmaceuticals, Inc. |
4'-fluoro nucleosides for the treatment of hcv
|
|
WO2014137930A1
(en)
|
2013-03-04 |
2014-09-12 |
Idenix Pharmaceuticals, Inc. |
Thiophosphate nucleosides for the treatment of hcv
|
|
WO2014137926A1
(en)
|
2013-03-04 |
2014-09-12 |
Idenix Pharmaceuticals, Inc. |
3'-deoxy nucleosides for the treatment of hcv
|
|
WO2014160484A1
(en)
|
2013-03-13 |
2014-10-02 |
Idenix Pharmaceuticals, Inc. |
Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
|
|
EP2981542B1
(en)
|
2013-04-01 |
2021-09-15 |
Idenix Pharmaceuticals LLC |
2',4'-fluoro nucleosides for the treatment of hcv
|
|
US10005779B2
(en)
|
2013-06-05 |
2018-06-26 |
Idenix Pharmaceuticals Llc |
1′,4′-thio nucleosides for the treatment of HCV
|
|
WO2015017713A1
(en)
|
2013-08-01 |
2015-02-05 |
Idenix Pharmaceuticals, Inc. |
D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
|
|
EP3038623A4
(en)
|
2013-09-09 |
2017-04-19 |
Melinta Therapeutics, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
KR20160070066A
(ko)
|
2013-09-09 |
2016-06-17 |
멜린타 테라퓨틱스, 인크. |
항균 화합물, 및 이의 제조 방법 및 이용 방법
|
|
US10202411B2
(en)
|
2014-04-16 |
2019-02-12 |
Idenix Pharmaceuticals Llc |
3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV
|
|
CA2979342A1
(en)
|
2015-03-11 |
2016-09-15 |
Melinta Therapeutics, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
WO2017193016A1
(en)
|
2016-05-06 |
2017-11-09 |
Melinta Therapeutics, Inc. |
Antimicrobials and methods of making and using same
|
|
EP4337646A4
(en)
*
|
2021-05-13 |
2025-05-21 |
Promega Corporation |
BIOLUMINESCENT DETECTION OF DNA SYNTHESIS
|
|
US20260062437A1
(en)
*
|
2022-08-26 |
2026-03-05 |
Regents Of The University Of Minnesota |
Antiviral compounds
|